Drug Shortage Report for ASMANEX TWISTHALER

Last updated on 2020-12-24 History
Report ID 101491
Drug Identification Number 02243596
Brand name ASMANEX TWISTHALER
Common or Proper name mometasone furoate dry powder inhaler
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 400MCG
Dosage form(s) POWDER
Route of administration INHALATION
Packaging size 30DOSE
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-02-28
Actual start date 2020-02-28
Estimated end date 2021-01-08
Actual end date 2020-12-23
Shortage status Resolved
Updated date 2020-12-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-12-17 English Compare
v2 2019-12-17 French Compare
v3 2020-02-18 English Compare
v4 2020-02-28 English Compare
v5 2020-02-29 English Compare
v6 2020-04-08 English Compare
v7 2020-07-09 English Compare
v8 2020-08-26 English Compare
v9 2020-09-02 English Compare
v10 2020-10-13 English Compare
v11 2020-12-03 English Compare
v12 2020-12-23 English Compare
v13 2020-12-23 French Compare
v14 2020-12-24 English Compare

Showing 1 to 14 of 14